Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05405244
What this trial is testing

Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

Who this might be right for
Overweight and ObesityEating Behavior
University of North Carolina, Chapel Hill 55
Post-approval studies (Phase 4)UnknownNCT04485845
What this trial is testing

Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

Who this might be right for
Metabolic SyndromeDiabete Type 2Kidney Insufficiency
Cairo University 39
Post-approval studies (Phase 4)Study completedNCT02670928
What this trial is testing

Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 130
Not applicableLooking for participantsNCT07703345
What this trial is testing

Salivary Apelin, Chemerin, Ghrelin, and Lipocalin-2 Levels in Diabetic Patients With Periodontitis

Who this might be right for
PeriodontitisType 2 Diabetes Mellitus (T2DM)
Necmettin Erbakan University 88
Post-approval studies (Phase 4)Study completedNCT03959501
What this trial is testing

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Who this might be right for
Type 2 DiabetesKetonemia
The University of Hong Kong 60
Early research (Phase 1)Study completedNCT06695572
What this trial is testing

Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Chong Kun Dang Pharmaceutical 30
Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Not applicableStudy completedNCT06642467
What this trial is testing

BGEM Use as Blood Glucose Prediction Model in T2DM Population of Indonesia

Who this might be right for
Diabete Type 2
Krida Wacana Christian University 885
Testing effectiveness (Phase 2)Study completedNCT00094796
What this trial is testing

Rosiglitazone to Reverse Metabolic Defects in Diabetes

Who this might be right for
Diabetes Mellitus, Type IIInsulin Resistance
National Heart, Lung, and Blood Institute (NHLBI) 70
Not applicableStudy completedNCT02798198
What this trial is testing

The Correlation Between the Pulmonary Function and Intrarenal Hemodynamics in 37 T2DM Patients in Early Period

Who this might be right for
Diabetes Mellitus, Type 2
Fourth People's Hospital of Shenyang 70
Not applicableNot Yet RecruitingNCT07117721
What this trial is testing

Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
El Katib Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03444584
What this trial is testing

Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 49
Not applicableLooking for participantsNCT03549754
What this trial is testing

ICaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

Who this might be right for
Type 2 DiabetesHypertensionChronic Kidney Disease+1 more
AstraZeneca 35,000
Early research (Phase 1)Ended earlyNCT00946972
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33
Not applicableStudy completedNCT05552339
What this trial is testing

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Bayer 348
Early research (Phase 1)Study completedNCT02058641
What this trial is testing

Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Atherosclerosis
GlaxoSmithKline 9
Not applicableUnknownNCT02701894
What this trial is testing

ALA on Glycemic Control in T2DM Participants

Who this might be right for
Type 2 Diabetes Mellitus
Unity Health Toronto 200
Not applicableStudy completedNCT07130370
What this trial is testing

Mindfulness-informed Intervention for Improving Diabetes Outcomes in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes (T2DM)
National University of Modern Languages 50
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Not applicableStudy completedNCT02588859
What this trial is testing

Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,200
Next Page